Jennifer Wargo

72PUBLICATIONS
681CO-AUTHORS
NanomedicineCancer therapy (excl. chemotherapy and radiation therapy)Innate immunityPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (72)

|Jul 31, 2026
A transferable gut microbiota-bile acid pathway programs nanomedicine pharmacokinetics and therapeutic response.

|Apr 13, 2026
Axitinib plus Avelumab in Recurrent/Metastatic Adenoid Cystic Carcinoma: Biomarker Analysis and Updated Results of the Phase II Trial.

Camilla O Hoff, Simon Heeke, Yoshitsugu Mitani

|Nov 24, 2025
Gut microbiota: a new factor modulating the immunizing potential of viral and cancer vaccines.

Agathe Carrier, Paolo Manghi, Carolina Alves Costa Silva

|Nov 14, 2025
Microbial signals in primary and metastatic brain tumors.

Golnaz Morad, Ashish V Damania, Brenda Melendez

|Oct 22, 2025
SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade.

Adam J Grippin, Christiano Marconi, Sage Copling

|Aug 20, 2025
Cancer-induced nerve injury promotes resistance to anti-PD-1 therapy.

Erez N Baruch, Frederico O Gleber-Netto, Priyadharsini Nagarajan

Pageof 12

Frequent Collaborators

19 joint publications

Michael A Davies

16 joint publications

P Andrew Futreal

16 joint publications

Nadim J Ajami

16 joint publications

Alexander J Lazar